• No results found

Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice

N/A
N/A
Protected

Academic year: 2020

Share "Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Longitudinal association between RAPID3 and Disease Activity Score in 28 joints; DAS28- ESR, Disease DAS28- ESR over time (N=207)
Table 2 Longitudinal association between RAPID3 (0–10) and DAS28- ESR, including individual components

References

Related documents

Einige Studien haben gezeigt, dass die atopische Dermatitis bei Neugeborenen und kleinen Kindern sich mit der Zeit verbessern kann, aber auch mit einem erhöhten

Chondrite-normalised REE patterns from Bearpaw ultramafic xenoliths: (a) clinopyroxenes from tectonite peridotites (LA-ICP-MS data from Table 12); (b) cumulate xenoliths (LA-ICP-

Keeping all these in mind, the present workers intended to engage his efforts on piper chaba a medical plant available in Bangladesh, to go through a systemic

We hypothesized that the introduction of a standardized sterile collection process would reduce the pediatric emergency department ’ s peripheral blood culture contamination rate

1) The compressive strength of fly ash concrete up-to 40% replacement level is slightly more than or equal to referral concrete at 28 and 56 days. Increase in strength after 56days

It is possible that the levels of ceramide synthase, ceramidase, and sphingosine kinase in different cell types may dictate how they respond to SapC-DOPS treatment, resulting

In this project the applications of GSM network for the design of a circuit to control the house hold appliances is shown, and also the design of the circuit and method to

Here we confirm by NMR and X-ray structural analysis of the dihydrochloride salt form that the ONC201 material produced by Oncoceutics is the angular [3,4-e] structure and not